Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 339 citing Goldberg: A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in.... (0.08 sec) 

Effect of rosiglitazone on the risk of myocardial infarction and death from …

- hopkinsmedicine.org [PDF] 
SE Nissen, K Wolski - New England Journal of Medicine, 2007 - content.nejm.org
From the Cleveland Clinic, Cleveland. Ad- dress reprint requests to Dr. Nissen at the Department
of Cardiovascular Medi- cine, Cleveland Clinic, 9500 Euclid Ave., Cleveland, OH 44195, or at
nissens@ccf. org. ... This article (10.1056/NEJMoa072761) was published at ...
Cited by 1339 - Related articles - BL Direct - All 83 versions

Secondary prevention of macrovascular events in patients with type 2 diabetes in …

- peoriaendocrine.com [PDF] 
JA Dormandy, B Charbonnel, DJA Eckland, E Erdmann … - The Lancet, 2005 - Elsevier
We did a prospective, randomised controlled trial in 5238 patients with type 2 diabetes who had
evidence of macrovascular disease. We recruited patients from primary-care practices and
hospitals. We assigned patients to oral pioglitazone titrated from 15 mg to 45 mg ...
Cited by 1164 - Related articles - BL Direct - All 41 versions

Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus …

- cardiobarbanza.com [PDF] 
DM Nathan, JB Buse, MB Davidson, E Ferrannini, RR … - Diabetologia, 2009 - Springer
Page 1. CONSENSUS STATEMENT UPDATE Medical management of
hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation
and adjustment of therapy A consensus statement from the American ...
Cited by 1054 - Related articles - BL Direct - All 92 versions

Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes …


AM Lincoff, K Wolski, SJ Nicholls, SE Nissen - Jama, 2007 - Am Med Assoc
You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do to make
your experience on this site better. ... Context Pioglitazone is widely used for glycemic ...
Cited by 331 - Related articles - BL Direct - All 7 versions

Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis

- infodiabetes.it [PDF] 
S Singh, YK Loke, CD Furberg - Jama, 2007 - Am Med Assoc
You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do to make
your experience on this site better. ... Context Recent reports of serious adverse events ...
Cited by 311 - Related articles - BL Direct - All 12 versions

Effect of pioglitazone compared with glimepiride on carotid intima-media thickness …

- touchcardiology.com [PDF] 
T Mazzone, PM Meyer, SB Feinstein, MH Davidson, GT … - Jama, 2006 - Am Med Assoc
Context Carotid artery intima-media thickness (CIMT) is a marker of coronary atherosclerosis
and independently predicts cardiovascular events, which are increased in type 2 diabetes mellitus
(DM). While studies of relatively short duration have suggested that thiazolidinediones ...
Cited by 221 - Related articles - BL Direct - All 13 versions

Comparison of vildagliptin and rosiglitazone monotherapy in patients with type 2 …


J Rosenstock, MA Baron, S Dejager, D Mills, A … - Diabetes Care, 2007 - ncbi.nlm.nih.gov
OBJECTIVE: To compare the efficacy and tolerability of vildagliptin and rosiglitazone during a
24-week treatment in drug-naïve patients with type 2 diabetes. RESEARCH DESIGN AND
METHODS: This was a double-blind, randomized, active-controlled, parallel-group, ...
Cited by 145 - Related articles - BL Direct - All 5 versions

Peroxisome proliferator activated receptors as transcriptional nodal points and …

- ahajournals.org
JD Brown, J Plutzky - Circulation, 2007 - Am Heart Assoc
Peroxisome proliferator–activated receptors (PPARs) are ligand-activated transcription factors
involved in the transcriptional regulation of key metabolic pathways such as lipid
metabolism, adipogenesis, and insulin sensitivity. More recent work implicates all 3 PPAR ...
Cited by 105 - Related articles - All 8 versions

Effect of rimonabant on progression of atherosclerosis in patients with abdominal …

- nursing2008.com
SE Nissen, SJ Nicholls, K Wolski, J Rodes-Cabau, CP … - Jama, 2008 - Am Med Assoc
You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do to make
your experience on this site better. ... Context Abdominal obesity is associated with ...
Cited by 99 - Related articles - BL Direct - All 5 versions

Comparison of pioglitazone vs glimepiride on progression of coronary …

- sbhci.org.br [PDF] 
SE Nissen, SJ Nicholls, K Wolski, R Nesto, S Kupfer, A … - Jama, 2008 - Am Med Assoc
You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do to make
your experience on this site better. ... Context No antidiabetic regimen has demonstrated ...
Cited by 94 - Related articles - BL Direct - All 11 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google